SCHEMBL779902

SCHEMBL779902

O=P(c1ccccc1)(c1ccccc1F)c1ccccc1F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
CA5A P35218 1/20 0.41
NPSR1 Q6W5P4 3/20 0.41
ALDH1A1 P00352 2/20 0.41
HTT P42858 2/20 0.41
POLB P06746 2/20 0.41
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
LMNA P02545 1/20 0.38
TOP1 P11387 1/20 0.37
CFTR P13569 1/20 0.37
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
GAA P10253 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL780209 0.95 POLB (0.44) CA2CA4CA5ANPSR1ALDH1A1
SCHEMBL777631 0.85 CES2 (0.39) ALDH1A1KMT2AMEN1TDP1GAA
SCHEMBL780290 0.80 ESR1 (0.52) CA2CA4CA5ANPSR1ALDH1A1
SCHEMBL4132505 0.78 CA2 (0.48) CA2CA4CA5AALDH1A1HTT
SCHEMBL8912817 0.78 NPSR1 (0.42) CA2CA4CA5ANPSR1ALDH1A1
SCHEMBL4762963 0.78 POLB (0.52) CA2CA4CA5ANPSR1ALDH1A1
SCHEMBL28483999 0.75 TOP1 (0.45) CA2CA4CA5ANPSR1ALDH1A1
SCHEMBL5827068 0.75 TOP1 (0.42) CA2CA4CA5ANPSR1ALDH1A1
SCHEMBL10794254 0.74 ESR1 (0.43) CA2CA4CA5ANPSR1HTT
Bromide SCHEMBL27277348 0.74 ACHE (0.33) CA2CA4CA5AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000024818-A1 CYCLIC OLIGOMER NANOCOMPOSITES TRITON SYSTEMS, INC. (US) 2000-05-04 WO claimed
US-20260085154-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT JSR CORPORATION (JP) 2026-03-26 US disclosed
WO-2025084303-A1 RESIN COMPOSITION, PREPREG, METAL-CLAD LAMINATE, AND METHOD FOR PRODUCING SAME AGC株式会社 2025-04-24 WO disclosed
WO-2025084304-A1 COMPOSITION, PREPREG, AND METAL-CLAD LAMINATED BOARD AGC株式会社 2025-04-24 WO disclosed
WO-2024257781-A1 THERMOSETTING RESIN COMPOSITION FOR FORMING WIRING BOARD, CURED PRODUCT, PREPREG, AND INTERLAYER INSULATING FILM JSR株式会社 2024-12-19 WO disclosed
US-12100809-B2 Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery MITSUBISHI CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
WO-2024053282-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATE, AND ELECTRONIC COMPONENT JSR株式会社 2024-03-14 WO disclosed
EP-4316814-A1 POLYMER, COMPOSITION, CURED PRODUCT, MULTILAYER BODY, AND ELECTRONIC COMPONENT JSR Corporation (JP) 2024-02-07 EP disclosed
US-20240026069-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATE, AND ELECTRONIC COMPONENT JSR CORPORATION (JP) 2024-01-25 US disclosed
WO-2022210095-A1 POLYMER, COMPOSITION, CURED PRODUCT, MULTILAYER BODY, AND ELECTRONIC COMPONENT JSR株式会社 2022-10-06 WO disclosed
US-20150188192-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2015-07-02 US disclosed
US-20150056503-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2015-02-26 US disclosed
US-20120177988-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-07-12 US disclosed
US-20120070731-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2012-03-22 US disclosed
US-20090325065-A1 NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY MITSUBISHI CHEMICAL CORPORATION (JP) 2009-12-31 US disclosed
EP-2012386-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY Mitsubishi Chemical Corporation (JP) 2009-01-07 EP disclosed
US-20080255287-A1 PHOSPHINE OXIDE CONTAINING PHTHALONITRILES THE GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRECTARY OF THE NAVY (US) 2008-10-16 US disclosed
US-20080255287-A1 PHOSPHINE OXIDE CONTAINING PHTHALONITRILES THE GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRECTARY OF THE NAVY (US) 2008-10-16 US disclosed
WO-2000024818-A1 CYCLIC OLIGOMER NANOCOMPOSITES TRITON SYSTEMS, INC. (US) 2000-05-04 WO disclosed
US-4698448-A Method for making aromatic phosphorus compounds ROHM GMBH (DE) 1987-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255287-A1 PHOSPHINE OXIDE CONTAINING PHTHALONITRILES PHOSPHO1, PBRM1, PFAS CA2 126/4885CA4 367/4885CA5A 2114/4885
US-20260085154-A1 POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT RER1, COL1A1, SMC1A CA2 4215/4885CA4 3533/4885CA5A 4669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.